Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Investors who lost money in IBRX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in EOSE after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, April 10, 2026 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX- V:...
-
Investors who lost money in NAVN after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today...
-
Chengdu, China, April 10, 2026 (GLOBE NEWSWIRE) -- JIADE LIMITED (Nasdaq: JDZG) (“JIADE” or the “Company”), a provider of one-stop comprehensive education support services for adult education...
-
Investors who lost money in APO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Investors who lost money in SLNO after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Investors who lost money in TCOM after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.